Ghrelin improves functional survival of engrafted adipose-derived mesenchymal stem cells in ischemic heart through PI3K/Akt signaling pathway

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Han, Dong ^a   Huang, Wei ^a   Ma, Sai ^a   Chen, Jiangwei ^a   Gao, Lina ^a   Liu, Tong ^a   Zhang, Rongqing ^a   Li, Xiujuan ^a   Li, Congye ^a   Fan, Miaomiao ^a   Chen, Yundai ^b   Cao, Feng ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GHRELIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

ADIPOSE DERIVED MESENCHYMAL STEM CELL; ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL THERAPY; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; BIOLOGICAL THERAPY; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; GHRELIN; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84927145381     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/858349     Document Type: Article

References (30)

1. J. C. Garbern and R. T. Lee, "Cardiac stem cell therapy and the promise of heart regeneration", Cell Stem Cell, vol. 12, no. 6, pp. 689-698, 2013.
2. W. Fan, K. Cheng, X. Qin et al., "mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo", Stem Cells, vol. 31, no. 1, pp. 203-214, 2013.
3. Q. Li, Y. Wang, and Z. Deng, "Pre-conditioned mesenchymal stem cells: a better way for cell-based therapy", Stem Cell Research and Therapy, vol. 4, no. 3, article 63, 2013.
4. A. Leri and P. Anversa, "Stemcells andmyocardial regeneration: cooperation wins over competition", Circulation, vol. 127, no. 2, pp. 165-168, 2013.
5. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, "Ghrelin is a growth-hormone-releasing acylated peptide fromstomach", Nature, vol. 402, no. 6762, pp. 656-660, 1999.
6. M. Kojima and K. Kangawa, "Structure and function of Ghrelin", Results and Problems in Cell Differentiation, vol. 46, pp. 89-115, 2008.
7. T. Tokudome, I. Kishimoto, M. Miyazato, and K. Kangawa, "Ghrelin and the cardiovascular system", Frontiers of Hormone Research, vol. 43, pp. 125-133, 2014.
8. W. G. Li, D. Gavrila, X. Liu et al., "Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells", Circulation, vol. 109, no. 18, pp. 2221-2226, 2004.
9. Y. Wang, K. Narsinh, L. Zhao et al., "Effects and mechanisms of ghrelin on cardiac microvascular endothelial cells in rats.", Cell biology international, vol. 35, no. 2, pp. 135-140, 2011.
10. E. Gao, Y. H. Lei, X. Shang et al., "A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse", Circulation Research, vol. 107, no. 12, pp. 1445-1453, 2010.
11. F. Cao, S. Lin, X. Xie et al., "In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery", Circulation, vol. 113, no. 7, pp. 1005-1014, 2006.
12. Q. Pan, X. Qin, S. Ma et al., "Myocardial protective effect of extracellular superoxide dismutase gene modified bone marrow mesenchymal stromal cells on infarcted mice hearts", Theranostics, vol. 4, no. 5, pp. 475-486, 2014.
13. Z. Zhang, S. Li, M. Cui et al., "Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways", Basic Research in Cardiology, vol. 108, no. 2, article 333, 2013.
14. J. H. Houtgraaf, W. K. den Dekker, B. M. van Dalen et al., "First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction", Journal of the American College of Cardiology, vol. 59, no. 5, pp. 539-540, 2012.
15. H. Mizuno, M. Tobita, and A. C. Uysal, "Concise review: adipose-derived stemcells as a novel tool for future regenerative medicine", Stem Cells, vol. 30, no. 5, pp. 804-810, 2012.
16. T. E. Robey, M. K. Saiget, H. Reinecke, and C. E. Murry, "Systems approaches to preventing transplanted cell death in cardiac repair", Journal of Molecular and Cellular Cardiology, vol. 45, no. 4, pp. 567-581, 2008.
17. G. Alloatti, E. Arnoletti, E. Bassino et al., "Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes", The American Journal of Physiology. Heart and Circulatory Physiology, vol. 299, no. 2, pp. H470-H481, 2010.
18. E. A. García and M. Korbonits, "Ghrelin and cardiovascular health", Current Opinion in Pharmacology, vol. 6, no. 2, pp. 142-147, 2006.
19. X. Xu, B. S. Jhun, C. H. Ha, and Z. G. Jin, "Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation", Endocrinology, vol. 149, no. 8, pp. 4183-4192, 2008.
20. K. Isoda, J. L. Young, A. Zirlik et al., "Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 3, pp. 611-617, 2006.
21. S. W. Kim, O. K. Choi, J. Y. Jung et al., "Ghrelin inhibits early osteogenic differentiation of C3H10T1/2 cells by suppressing Runx2 expression and enhancing PPARγ and C/EBPα expression", Journal of Cellular Biochemistry, vol. 106, no. 4, pp. 626-632, 2009.
22. U. Gurriarán-Rodríguez, I. Santos-Zas, O. Al-Massadi et al., "The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system", The Journal of Biological Chemistry, vol. 287, no. 45, pp. 38379-38389, 2012.
23. L. Bonfili, M. Cuccioloni, V. Cecarini et al., "Ghrelin induces apoptosis in colon adenocarcinoma cells via proteasome inhibition and autophagy induction", Apoptosis, vol. 18, no. 10, pp. 1188-1200, 2013.
24. P. Cassoni, M. Papotti, C. Ghè et al., "Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines", The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 4, pp. 1738-1745, 2001.
25. M. Grunewald, I. Avraham, Y. Dor et al., "VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells", Cell, vol. 124, no. 1, pp. 175-189, 2006.
26. W. Fan, D. Sun, J. Liu et al., "Adipose stromal cells amplify angiogenic signaling via the VEGF/mTOR/Akt pathway in a murine hindlimb ischemia model: a 3D multimodality imaging study", PLoS ONE, vol. 7, no. 9, Article ID e45621, 2012.
27. A.-K. Olsson, A. Dimberg, J. Kreuger, and L. Claesson-Welsh, "VEGF receptor signalling-in control of vascular function", Nature Reviews Molecular Cell Biology, vol. 7, no. 5, pp. 359-371, 2006.
28. F. Cao, Z. Li, A. Lee et al., "Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation", Cancer Research, vol. 69, no. 7, pp. 2709-2713, 2009.
29. J. Isgaard, A. Barlind, and I. Johansson, "Cardiovascular effects of ghrelin and growth hormone secretagogues", Cardiovascular and Hematological Disorders. Drug Targets, vol. 8, no. 2, pp. 133-137, 2008.
30. G. Togliatto, A. Trombetta, P. Dentelli et al., "Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression", Journal of the American Heart Association, vol. 2, no. 6, Article ID e000376, 2013.